当前位置:首页 - 行情中心 - *ST目药(600671) - 财务分析

*ST目药

(600671)

  

流通市值:10.82亿  总市值:10.83亿
流通股本:1.22亿   总股本:1.22亿

*ST目药(600671)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润-0.10亿元,每股收益-0.08元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益4585.00万元,未分配利润-28133.29万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产31267.93万元,负债26682.93万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入38,331,441.82121,778,535.8586,107,172.1950,953,892.51
营业总成本49,496,998.71151,535,713.26106,559,302.7266,993,515.12
营业利润-10,916,187.17-37,569,436.7-22,720,751.94-20,686,620.89
利润总额-10,072,671.6-36,310,173.34-27,526,011.88-23,643,013.11
净利润-10,098,459.85-39,295,530.62-27,526,126.34-23,643,127.57
其他综合收益----
综合收益总额-10,098,459.85-39,295,530.62-27,526,126.34-23,643,127.57
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计150,378,809.16181,499,253.27181,058,043.1592,889,548.75
非流动资产合计162,300,510.48164,789,303.06159,384,458.68163,716,299.78
资产总计312,679,319.64346,288,556.33340,442,501.83256,605,848.53
流动负债合计198,810,840.55220,378,222.75292,771,437.61204,748,491.2
非流动负债合计68,018,478.3569,961,872.9970,032,564.8371,020,756.59
负债合计266,829,318.9290,340,095.74362,804,002.44275,769,247.79
归属于母公司股东权益合计27,415,273.5937,138,057.07-42,085,270.85-38,048,313.18
股东权益合计45,850,000.7455,948,460.59-22,361,500.61-19,163,399.26
负债和股东权益合计312,679,319.64346,288,556.33340,442,501.83256,605,848.53
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计37,709,969.69136,079,847.2290,357,676.1952,124,449.26
经营活动现金流出小计41,283,693.37156,508,668.14119,239,918.2782,375,498.42
经营活动产生的现金流量净额-3,573,723.68-20,428,820.92-28,882,242.08-30,251,049.16
投资活动现金流入小计-167,98138,870.41-
投资活动现金流出小计3,057,657.628,994,391.054,309,364.222,479,370.8
投资活动产生的现金流量净额-3,057,657.62-8,826,410.05-4,270,493.81-2,479,370.8
筹资活动现金流入小计121,900,000258,308,673.78258,308,673.7885,900,000
筹资活动现金流出小计157,310,537.66173,483,326.73166,602,022.8789,037,292.11
筹资活动产生的现金流量净额-35,410,537.6684,825,347.0591,706,650.91-3,137,292.11
汇率变动对现金及现金等价物的影响----
现金及现金等价物净增加额-42,041,918.9655,570,116.0858,553,915.02-35,867,712.07
期末现金及现金等价物余额55,920,693.4697,962,612.42100,945,911.366,524,284.27
TOP↑